Gambro gets products delivery contract in Kuwait

Gambro gets products delivery contract in Kuwait Stockholm, Sweden - Gambro AB (Stockholm Stock Exchange: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, today announced that it has, together with its partner Advanced Technology Company in Kuwait, been granted a three year supply contract with the Ministry of Health in Kuwait. The contract includes disposable products needed for performing hemodialysis and on-line hemodiafiltration treatments on Gambro equipment in Kuwait. The total contract represents for Gambro a value of about SEK 20 M. For Gambro and Advanced Technology Company this contract represents an important step in the cooperation with the Ministry of Health in Kuwait. For further information please contact: Bengt Modéer, Senior Vice President, Corporate Communications, tel. +46-8-613 65 00, +46-70-513 65 33 Anna Augustson, European Investor Relations Manager, tel. +46-8-613 65 35, +46-70-513 65 34 Lennart la Fleur, President, Gambro/Hospal Export, tel. +46-46-16 92 58 Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology (BCT). Gambro is one of the leading providers of kidney dialysis services in the world. Gambro treats about 42,000 patients in 565 clinics worldwide. Renal care products comprise dialyzers, dialysis machines, blood lines and dialysis concentrates. BCT includes products for the separation and handling of blood components. The group, with revenue of approximately SEK 18 billion (USD 2.2 billion), has approximately 17,000 employees in some 40 countries. ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1999/09/24/19990924BIT00210/bit0001.pdf http://www.bit.se/bitonline/1999/09/24/19990924BIT00210/bit0002.doc

About Us

Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology. The group, with revenue of approximately SEK 18 billion (USD 2.2 billion), has approximately 17,000 employees in some 40 countries.

Subscribe